Momenta Pharma, Sandoz sue Amphastar, Watson
The lawsuit alleges that under an agreement signed with Watson Pharmaceuticals, Amphastar has given right to market, sell and distribute Enoxaparin Sodium Injection in the US, infringing Momenta’s
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.